Needham downgrades Biogen on slow growth of Alzheimers drug
| SCHLX Fund | USD 39.10 0.69 1.80% |
Slightly above 53% of Deutsche Health's investors are presently thinking to get in. The analysis of overall sentiment of trading Deutsche Health And mutual fund suggests that some investors are interested at this time. Deutsche Health's investing sentiment can be driven by a variety of factors including economic data, Deutsche Health's earnings reports, geopolitical events, and overall market trends.
Deutsche |
Investing.com - Needham downgraded Biogen Inc on Monday, citing slower-than-expected growth for its Alzheimers drug, Leqembi, and a lack of major catalysts over the next 12 months.
Read at finance.yahoo.com
 |
Deutsche Health Fundamental Analysis
We analyze Deutsche Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
Deutsche Health is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
Deutsche Health And Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Health mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Health could also be used in its relative valuation, which is a method of valuing Deutsche Health by comparing valuation metrics with similar companies.
Peers
Deutsche Health Related Equities
| KTRAX | Deutsche Global | 0.33 | ||||
| KTRCX | Deutsche Global | 0.22 | ||||
| KTCCX | Deutsche Science | 0.15 | ||||
| KTCSX | Deutsche Science | 0.12 | ||||
| SRMAX | Deutsche Short | 0.10 | ||||
| SRMCX | Deutsche Short | 0.10 | ||||
| SRMSX | Deutsche Short | 0.10 | ||||
| KTCAX | Deutsche Science | 0.10 | ||||
| KTCIX | Deutsche Science | 0.02 | ||||
| GCGGX | Deutsche Gnma | 0.09 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Health financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Health security.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |